Zentalis Pharmaceuticals, Inc. (ZNTL) Earnings
|
Expand Research on ZNTL
| Next EPS Date | N/A | EPS Growth Rate | N/A |
|---|---|---|---|
| Average EPS % Beat Rate | +19.3% | Revenue Growth Rate | N/A |
| Average % Move 1-Wk after EPS | -7.7% | Normal Earnings Time | After Close |
| Date | Qtr | EPS | Cons. | Surprise | Revs | Cons. | Gd. | 1-Week % | 1-Day % | Details | |
|---|---|---|---|---|---|---|---|---|---|---|---|
3/6/26  |
Q425 | N/A | -$0.48 | N/A | N/A | N/A | N/A | N/A | N/A | ||
| 3/4/26 |
Q425 | N/A | -$0.48 | N/A | N/A | N/A | N/A | N/A | N/A | ||
| 11/10/25 | Q325 | -$0.37 | -$0.53 | +$0.16 | N/A | N/A | N/A |  | | Details | |
| 11/7/25 |
Q325 | N/A | -$0.53 | N/A | N/A | N/A | N/A | N/A | N/A | ||
| 11/5/25 |
Q325 | N/A | -$0.53 | N/A | N/A | N/A | N/A | N/A | N/A | ||
| 11/3/25 |
Q325 | N/A | -$0.53 | N/A | N/A | N/A | N/A | N/A | N/A | ||
| 8/6/25 |
Q225 | -$0.37 | -$0.54 | +$0.17 | N/A | N/A | N/A | | | Details | |
| 5/9/25 |
Q125 | N/A | -$0.68 | N/A | N/A | N/A | N/A | N/A | N/A |
